

CLASSIFICATION: SELECTIVE ESTROGEN RECEPTOR MODULATOR (SERM)
ACTIVE SUBSTANCE: TAMOXIFEN CITRATE
FORM: 30 TABLETS x 20 MG
ACTIVE HALF-LIFE: ~5–7 DAYS
DOSAGE: MEN 20-120 MG/DAY
ACNE: POSSIBLE
WATER RETENTION: LOW TO MODERATE
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: RARE
AROMATIZATION: NONE
MANUFACTURER: ACTAVIS
Tamoxifen is a selective estrogen receptor modulator (SERM) used under physician supervision for approved indications such as risk reduction and treatment settings in certain types of breast cancer. A SERM does not "turn off" estrogen production; instead, it modulates how estrogen signals in specific tissues—acting as an antagonist in some (e.g., breast) and a partial agonist in others (e.g., bone). For athletes and fitness-minded adults who are working with a clinician, this profile is sometimes discussed when managing estrogen-related concerns as part of a broader, medically supervised plan. This product is prescription-only; use it strictly according to your licensed healthcare provider's directions.
Estrogen exerts its effects by binding to nuclear estrogen receptors (ERα and ERβ). Tamoxifen and its active metabolites (notably endoxifen and 4-hydroxytamoxifen) bind those receptors and change gene transcription in a tissue-selective manner. In breast tissue, this often results in functional antagonism—blunting estrogen's proliferative signaling. In bone, partial agonism can help maintain mineral density, which is one reason SERMs are differentiated from aromatase inhibitors (AIs). Because tamoxifen does not inhibit aromatase, circulating estradiol can remain measurable; the effect is primarily at the receptor level.
Competitive training, body composition phases, and complex supplementation protocols can intersect with endocrine health. Under physician guidance, SERMs may be discussed in contexts where estrogenic balance matters—for example, addressing receptor-level effects while leaving aromatase activity unchanged. Tamoxifen is not a general wellness supplement and should not be self-administered for cosmetic goals. Any use must be guided by diagnostics (history, physical, labs), risk–benefit assessment, and a monitoring plan.
Tamoxifen is well absorbed orally and undergoes hepatic metabolism (CYP2D6 and CYP3A4 pathways) to active metabolites. The parent compound's terminal half-life is typically ~5–7 days, while active metabolites can persist longer; steady pharmacodynamic effects may reflect this extended activity. Clinician-guided therapy is individualized by indication, body mass, comorbidities, and concomitant medications. Because the mechanism is receptor-mediated, benefits accrue over consistent daily use rather than immediate, acute changes.
Your clinician selects the tool that fits your physiology and goals. Unsupervised switching between classes is not recommended.
Like all prescription medicines, tamoxifen can cause adverse effects. Common reactions may include hot flashes, leg cramps, mild GI upset, or mood changes. Rare but serious risks—whose absolute rate depends on the population and indication—can include thromboembolic events (e.g., DVT/PE), endometrial changes, and ocular issues; report leg swelling/pain, chest pain, sudden shortness of breath, or visual changes immediately. Because tamoxifen is metabolized hepatically, clinicians may order periodic liver function tests in longer courses or when clinically indicated. If you take medications that affect CYP2D6 (some SSRIs, for example) or CYP3A4, your prescriber may review potential interactions and adjust therapy.
For FDA-vetted information on dosing, interactions, contraindications, and black box warnings, consult an authoritative source such as MedlinePlus: Tamoxifen. Your clinician will apply those principles to your specific case.
Training outcomes depend primarily on progressive overload, adequate energy and protein intake (often 1.6–2.2 g/kg/day for strength and physique goals), sleep (7–9 hours), and stress control. Medicines like tamoxifen—when indicated—address specific receptor-level questions but do not replace fundamentals. Discuss any performance supplement or cycle history honestly with your clinician so they can protect your cardiovascular, hepatic, and endocrine health and set up a monitoring plan (labs, vitals, symptom review).
Related prescription options discussed with clinicians for estrogen management and recovery planning:
This listing is for genuine Actavis Tamoxifen 20 mg tablets (30 count). Store at room temperature, away from moisture, heat, and light. Keep out of reach of children. Use only if prescribed and sourced legally in your jurisdiction. Discreet USA shipping; secure checkout.
Medical & legal disclaimer: For informational purposes only; not medical advice. Use prescription medicines only under a licensed clinician's supervision and according to local laws.
No. Tamoxifen is a SERM; it modulates how estrogen signals at the receptor. Circulating estradiol may remain measurable. If the goal is to lower estrogen production, clinicians consider aromatase inhibitors.
The parent drug's half-life is roughly 5–7 days, with active metabolites that may persist longer. Your prescriber bases duration on indication, response, and safety monitoring.
No. Tamoxifen is prescription-only and requires medical evaluation, dosing guidance, and monitoring for interactions and rare but serious side effects (e.g., blood clots, vision changes).
Tamoxifen blocks estrogen signaling in certain tissues (receptor modulator). Aromatase inhibitors lower estrogen production by blocking the aromatase enzyme. Clinicians select based on labs, goals, and risk profile.
Yes. Drugs that affect CYP2D6 or CYP3A4 (some SSRIs, antifungals, macrolide antibiotics, anticonvulsants) may alter tamoxifen metabolism. Provide a full medication and supplement list for review.
Please log in to write TAMOXIFEN 20 MG review.
SELECTIVE ESTROGEN RECEPTOR MODULATOR
ACTIVE SUBSTANCE: TAMOXIFEN CITRATE
FORM: 30 PILLS x 20 MG
ACTIVE HALF-LIFE: 5 DAYS
DOSAGE: MEN 20-120 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: VERY LOW
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
Advanced Bulking Steroid Cycle
- Testo Blend 350 mg x 4 Vials
- Deca 300 mg x 3 Vials
- Dianabol 20 mg x 100 Pills
- Arimidex 1 mg x 100 Pills
- HCG 5000 IU x 3 Vials
- Nolvadex 20 mg x 100 Pills
- Clomid 50 mg x 100 Pills
Made by Dragon Pharma
Warning! High dosed gear, can cause pain and reaction at the injection site!`
Warm high concentration 350 mg<
before administration
in order to avoid high levels of PIP
and massage afterward.
THIS KIT CONTAINS:
1 x DIANABOL 20 MG by Dragon Pharma (Size: 100 tabs)
2 x HCG 5000 IU, 2 ml vial by Dragon Pharma
1 x NOLVADEX 20mg by Dragon Pharma (Size: 100 tabs)
1 x ARIMIDEX 1 MG by Dragon Pharma (Size: 100 tabs)
1 x CLOMID 50mg by Dragon Pharma (Size: 100 tabs)
1 x DECA 500 by Dragon Pharma (Size: 1 vial)
3 x SUSTANON 270, 10ml vial by Dragon Pharma (Size: 3 vials)